<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T15:52:48.9513548+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-DJI-C-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Support the National HIV and Tuberculosis Programmes in scaling up treatment and care services nationwide - Djibouti (01-Jul-2018-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Djibouti, TB/HIV, United Nations Development Programme (UNDP Djibouti)This program has the following goals: To reduce the prevalence of tuberculosis by 25% by 2025.  To halve new HIV infections by 2022.  To improve the life expectancy and quality of life for people infected and affected by HIV and comorbidity agents. The objectives of this program are: To improve screening for new cases of tuberculosis with a view to reporting 3200 new cases by 2020.  To improve treatment success to achieve a rate in excess of 85% from 2016 and to maintain it at that level until 2020.  To ensure that the prevalence of primary resistance amongst new cases does not exceed 1.8% between now and 2020.  To reduce the death rate among cases of co-infection from 17% to 15% by 2020.  For the incidence of HIV to halve by 2022.  For the HIV mortality rate to be reduced by 70% by 2022</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="DJI-C-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-07-01" />
		<activity-date type="2" iso-date="2018-07-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Marie, JN BAPTISTE</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>marie.jnbaptiste@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="DJ" percentage="100">
			<narrative xml:lang="en">Djibouti</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="31">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="35">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="6">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="28">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Other intervention(s) for PMTCT</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention, diagnosis and treatment of opportunistic infections</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="29">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-07-01">735851.39</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-07-01">1791342.09</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-07-01">2389230.51</value>
		</budget>
		<transaction ref="388f995b-73da-4967-9322-c47af03973ef">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-11-26" />
			<value currency="USD" value-date="2018-11-26">398844.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="77a11969-30da-4444-a459-8d899342ca0f">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-06-18" />
			<value currency="USD" value-date="2020-06-18">410458.57</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a96c458a-c358-4429-92dd-e493a25307cc">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-10-05" />
			<value currency="USD" value-date="2018-10-05">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="995fe896-ade9-4838-a544-1eb373e38594">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-10-09" />
			<value currency="USD" value-date="2018-10-09">1400947.85</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6f8ca69f-8bb3-4f2e-8cf9-cd45dc22aa9a">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-09-25" />
			<value currency="USD" value-date="2019-09-25">2386282.49</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7e3fa69b-80ca-48cd-8ea7-546e2438740e">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-09-30" />
			<value currency="USD" value-date="2021-09-30">-604.54</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2fdbf158-7838-46df-bcbc-ee06772e6fdd">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-08-07" />
			<value currency="USD" value-date="2019-08-07">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5f596384-aff8-4c33-bb3d-a99202af2c27">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-10" />
			<value currency="USD" value-date="2019-10-10">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="41d33bb9-7d1b-424e-9172-0e8d92cb9482">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-06-24" />
			<value currency="USD" value-date="2020-06-24">410458.57</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d368f1e1-1eeb-4f3b-8d62-23c7a41bf342">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-10-11" />
			<value currency="USD" value-date="2018-10-11">1114620.85</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d2dbc324-4e37-43a6-9399-65e2074b8671">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-11-27" />
			<value currency="USD" value-date="2018-11-27">398844.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="105f5f40-5b7d-4cb2-8bae-80d760c4398b">
			<transaction-type code="7" />
			<transaction-date iso-date="2021-09-01" />
			<value currency="USD" value-date="2021-09-01">-604.54</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c8ec0844-dd73-4205-a646-78f3a8e47d08">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-10-19" />
			<value currency="USD" value-date="2018-10-19">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c8b242a0-08dd-492e-83dd-399527cddf35">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-21" />
			<value currency="USD" value-date="2020-04-21">377683.35</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c33a60fc-07f4-4d82-9b97-deab359f1021">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-09-26" />
			<value currency="USD" value-date="2019-09-26">1324573.64</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4d710f00-b3df-45d5-b503-654f140d3a3a">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-11-15" />
			<value currency="USD" value-date="2018-11-15">286327.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="db6ebd31-20e4-482d-8c5b-b11f13bb9ed5">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-02-11" />
			<value currency="USD" value-date="2020-02-11">684025.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/DJI-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for DJI-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="63.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="95.19" />
					<actual value="75.50" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.20" />
					<actual value="65.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="50.00" />
					<actual value="17.50" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="54.85" />
					<actual value="33.90" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="60.53" />
					<actual value="44.70" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="2269" />
					<actual value="1825" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2261" />
					<actual value="1701" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="1134" />
					<actual value="1013" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="72" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70" />
					<actual value="53" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="36" />
					<actual value="41" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.31" />
					<actual value="82.20" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="84.97" />
					<actual value="84.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="36" />
					<actual value="40" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70" />
					<actual value="49" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="72" />
					<actual value="44" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="11.50" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="85.00" />
					<actual value="11.90" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="80.00" />
					<actual value="20.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="49.40" />
					<actual value="31.20" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="35.85" />
					<actual value="32.60" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="41.81" />
					<actual value="42.80" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people who were tested for HIV and received their results during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="29525" />
					<actual value="26535" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="32478" />
					<actual value="22170" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="13421" />
					<actual value="16036" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for DJI-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="25.62" />
					<actual value="25.62" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="0.95" />
					<actual value="0.95" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="0.78" />
					<actual value="0.18" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="35" />
					<actual value="28" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="35" />
					<actual value="28" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="35" />
					<actual value="25" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="4.30" />
					<actual value="4.30" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="4.30" />
					<actual value="4.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="4.30" />
					<actual value="4.70" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for DJI-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="71.00" />
					<actual value="65.75" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="80.82" />
					<actual value="71.43" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.28" />
					<actual value="68.18" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="79.98" />
					<actual value="70.53" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="85.01" />
					<actual value="68.38" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.01" />
					<actual value="67.71" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="94.00" />
					<actual value="97.15" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-12-31" />
					<target value="95.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="100.00" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-DJI-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against HIV and Tuberculosis  in Djibouti - Djibouti (01-Jan-2016-30-Jun-2018)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">HIV and AIDS is a major public health problem in the Republic of Djibouti: there is a generalized epidemic with an estimated prevalence level of 2.9 percent and concentrated among some population at higher risk (2014 IBBS study estimating the prevalence of HIV among female sex workers at 13%).  With regards to tuberculosis (TB), Djibouti is ranked fifth in the world in terms of TB incidence and additionally, has a high incidence of TB/HIV co-infection.  Furthermore, the level of multidrug-resistant tuberculosis (MDR-TB) is estimated at 3.7 in new cases and 37.8 in previously treated cases, according to a newly conducted Drug Resistance Survey.  This TB/HIV grant will focus on reducing new HIV infections by targeting both the general population and key populations, through behavioral change activities which will include condom promotion, counselling and testing, and diagnostic and treatment of sexually transmitted infections (STIs).  Moreover, the program will scale out access to treatment and care for people living with HIV, including pregnant women, children and co-infected patients.  With regards to the TB component, the program aims at increasing the detection rate among the general population and key populations, such as refugees and prisoners.  In addition, it will provide diagnostic, treatment and care for drug-resistant TB.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="DJI-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2016-01-01" />
		<activity-date type="2" iso-date="2016-01-01" />
		<activity-date type="3" iso-date="2018-06-30" />
		<activity-date type="4" iso-date="2018-06-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Marie, JN BAPTISTE</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>marie.jnbaptiste@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="DJ" percentage="100">
			<narrative xml:lang="en">Djibouti</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="100">
			<narrative xml:lang="en">TB/HIV</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="bbea7fcc-9a67-456d-966f-b4348156bbdc">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-15" />
			<value currency="USD" value-date="2017-12-15">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3ec55e9a-56b5-40b5-895a-5f8406ea92e1">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-04-13" />
			<value currency="USD" value-date="2018-04-13">-25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8b8a1157-1738-42dc-8a84-7a963af94cdc">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-02-18" />
			<value currency="USD" value-date="2016-02-18">6853574.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dbe0b5d5-3892-42e5-8c67-2502014af97a">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-11-15" />
			<value currency="USD" value-date="2017-11-15">537262.70</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6520d3ae-4f5e-40fd-8ae4-7667000179cd">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-06-12" />
			<value currency="USD" value-date="2018-06-12">172946.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="075574b8-a8e8-4613-b2c3-1adcf6536327">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-08-23" />
			<value currency="USD" value-date="2016-08-23">1400314.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5410b796-c406-4920-935d-565f01492795">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-02-19" />
			<value currency="USD" value-date="2016-02-19">3065401.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0794c87e-90a3-4e12-9ab5-d89f345d7161">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-11-16" />
			<value currency="USD" value-date="2017-11-16">364316.70</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0301433e-cf53-49c7-822f-cb9ca3957ba7">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-05-23" />
			<value currency="USD" value-date="2017-05-23">2387859.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to DJI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Djibouti)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/DJI-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for DJI-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100.00" />
					<actual value="92.00" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="100.00" />
					<actual value="78.40" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="65.08" />
					<actual value="87.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="87.16" />
					<actual value="79.50" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="85.03" />
					<actual value="85.20" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="85.03" />
					<actual value="87.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="37.53" />
					<actual value="11.20" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="37.53" />
					<actual value="0" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="90.63" />
					<actual value="73.80" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100.00" />
					<actual value="70.80" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="100.00" />
					<actual value="75.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="752" />
					<actual value="602" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="752" />
					<actual value="471" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="809" />
					<actual value="529" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="34.93" />
					<actual value="34.20" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="36.13" />
					<actual value="31.00" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="37.82" />
					<actual value="35.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="22.91" />
					<actual value="9.40" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="17.18" />
					<actual value="0" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (&lt;1000 copies/ml)</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="79.84" />
					<actual value="46.70" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="46" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2017-07-01" />
					<period-end iso-date="2017-12-31" />
					<target value="63" />
					<actual value="36" />
				</period>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="63" />
					<actual value="39" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for DJI-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2017-01-01" />
					<period-end iso-date="2017-06-30" />
					<target value="75.00" />
					<actual value="70.42" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>